Oxford Asset Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-22,262
| Closed | -$40.7K | – | 273 |
|
|
2024
Q1 | $40.7K | Buy |
+22,262
| New | +$40.7K | 0.04% | 243 |
|
|
2019
Q4 | – | Sell |
-91,571
| Closed | -$359K | – | 1725 |
|
|
2019
Q3 | $359K | Sell |
91,571
-30,445
| -25% | -$119K | 0.01% | 1398 |
|
|
2019
Q2 | $591K | Sell |
122,016
-62,676
| -34% | -$304K | 0.01% | 1199 |
|
|
2019
Q1 | $1.51M | Sell |
184,692
-146,287
| -44% | -$1.2M | 0.03% | 720 |
|
|
2018
Q4 | $1.83M | Buy |
+330,979
| New | +$1.83M | 0.05% | 512 |
|
|
2018
Q3 | – | Sell |
-116,062
| Closed | -$1.12M | – | 1668 |
|
|
2018
Q2 | $1.12M | Sell |
116,062
-31,048
| -21% | -$299K | 0.02% | 974 |
|
|
2018
Q1 | $1.4M | Sell |
147,110
-27,642
| -16% | -$263K | 0.03% | 765 |
|
|
2017
Q4 | $2.61M | Sell |
174,752
-29,708
| -15% | -$444K | 0.06% | 447 |
|
|
2017
Q3 | $4M | Buy |
204,460
+135,460
| +196% | +$2.65M | 0.08% | 289 |
|
|
2017
Q2 | $992K | Buy |
+69,000
| New | +$992K | 0.02% | 891 |
|